Dabigatran etexilate (generic)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dabigatran etexilate (generic), covering 2024-08-13 to 2024-08-13. Get the full timeline:
Most recent: FDA Approved: DABIGATRAN ETEXILATE — Original Application (XLCare Pharmaceuticals, Inc.)